An in vitro study on factors affecting endotoxin neutralization in human plasma using the Limulus amebocyte lysate test.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
18 02 2021
18 02 2021
Historique:
received:
13
05
2020
accepted:
21
01
2021
entrez:
19
2
2021
pubmed:
20
2
2021
medline:
15
12
2021
Statut:
epublish
Résumé
Endotoxin neutralization, caused by plasma components, makes it difficult to detect endotoxins in human blood. In this study, we investigated which factors influence the recovery of endotoxins using limulus ameobocyte lysate (LAL)-based assays. The individual factors that were examined in more detail were lipoprotein content, type of blood anticoagulation, kinetics and serum levels of divalent cations. Furthermore, it was investigated whether there is a direct correlation between LAL activity and monocyte activation. We could show that polyanionic heparin increases endotoxin recovery in blood, while citrate anticoagulation promotes endotoxin neutralization. Furthermore, we could show that the endotoxin activity in human plasma and serum decreases strongly over time. Time-dependent endotoxin neutralization reaches its maximum after 4-6 h incubation. By means of filtration tests we could determine that endotoxins in the plasma bind to lipoproteins but do not influence their activity. Comparative measurements have shown that high LAL activity of endotoxins in plasma simultaneously possesses high monocyte activating properties in whole blood. For the maximum recovery of endotoxins in human blood the physiological calcium and magnesium concentrations are sufficient. In this study, it was shown that the endotoxin neutralizing plasma components have a molecular weight similar to β2-microglobulin (11.7 kDa). For the exact identification of the endotoxin neutralizing plasma components, which caused a modulation of the immunostimulating endotoxin activity, further investigations have to be carried out in the future.
Identifiants
pubmed: 33603020
doi: 10.1038/s41598-021-83487-4
pii: 10.1038/s41598-021-83487-4
pmc: PMC7893160
doi:
Substances chimiques
Endotoxins
0
Lipoproteins
0
Magnesium
I38ZP9992A
Calcium
SY7Q814VUP
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
4192Références
Diabetes. 2002 Jun;51(6):1949-56
pubmed: 12031985
Mol Biochem Parasitol. 1980 Oct;2(1):31-8
pubmed: 7464858
Infect Immun. 1996 Dec;64(12):4922-7
pubmed: 8945527
J Lab Clin Med. 1990 Aug;116(2):153-61
pubmed: 2203854
Nature. 2002 Dec 19-26;420(6917):885-91
pubmed: 12490963
Arterioscler Thromb Vasc Biol. 1995 Nov;15(11):1987-94
pubmed: 7583580
J Endotoxin Res. 2005;11(5):299-303
pubmed: 16263003
Infect Immun. 1999 Apr;67(4):2005-9
pubmed: 10085049
Res Nurs Health. 2007 Jun;30(3):250-60
pubmed: 17514720
PLoS One. 2013 Nov 25;8(11):e80192
pubmed: 24282521
J Endotoxin Res. 2000;6(3):249-56
pubmed: 11052180
Infect Immun. 1992 Feb;60(2):596-601
pubmed: 1730494
Int J Mol Sci. 2019 Oct 31;20(21):
pubmed: 31683553
Lancet. 2000 Sep 9;356(9233):930-3
pubmed: 11036910
Annu Rev Immunol. 1995;13:61-92
pubmed: 7612236
J Inflamm (Lond). 2016 Jul 30;13:24
pubmed: 27478413
Prog Clin Biol Res. 1995;392:317-26
pubmed: 8524937
Immunol Today. 1991 Nov;12(11):404-10
pubmed: 1838480
Arterioscler Thromb. 1992 Mar;12(3):341-7
pubmed: 1547193
J Biol Chem. 2006 Jan 20;281(3):1636-43
pubmed: 16293630
Infect Immun. 1993 Aug;61(8):3496-502
pubmed: 8335381
Trends Cardiovasc Med. 2003 Aug;13(6):226-31
pubmed: 12922018
Biochim Biophys Acta. 2006 Sep;1758(9):1513-22
pubmed: 16854372
Biologicals. 2018 May;53:1-9
pubmed: 29685804
J Clin Pathol. 1981 Dec;34(12):1368-74
pubmed: 7328184
Langenbecks Arch Surg. 2010 Aug;395(6):597-605
pubmed: 20582603
Antimicrob Agents Chemother. 2002 Jul;46(7):2132-6
pubmed: 12069965
Nat Immunol. 2014 Feb;15(2):152-60
pubmed: 24317040
Infect Immun. 1999 Dec;67(12):6445-53
pubmed: 10569762
Clin Microbiol Rev. 2006 Jul;19(3):491-511
pubmed: 16847082
Eur J Immunol. 2003 Jun;33(6):1586-92
pubmed: 12778476
J Biol Chem. 1990 Aug 15;265(23):14023-9
pubmed: 2199450
J Bacteriol. 1966 Nov;92(5):1493-509
pubmed: 4288609
Crit Care. 2007;11(3):R69
pubmed: 17594475
Thromb Diath Haemorrh. 1968 Mar 31;19(1):186-97
pubmed: 5690028
Sci Rep. 2017 Mar 20;7:44750
pubmed: 28317862
PDA J Pharm Sci Technol. 2017 Nov-Dec;71(6):478-487
pubmed: 28928294
Trends Microbiol. 2000 Sep;8(9):402-10
pubmed: 10989307
Cytokine. 1996 Feb;8(2):152-60
pubmed: 8777274
Scand J Clin Lab Invest. 1996 Oct;56(6):533-43
pubmed: 8903115
Innate Immun. 2011 Oct;17(5):427-38
pubmed: 20682588
Clin Chim Acta. 1994 Apr;226(1):109-12
pubmed: 8070129
Clin Microbiol Rev. 1995 Apr;8(2):268-92
pubmed: 7621402
Clin Infect Dis. 2005 Nov 15;41 Suppl 7:S498-503
pubmed: 16237653
Appl Environ Microbiol. 1983 Apr;45(4):1342-50
pubmed: 6859851
Circulation. 2008 Oct 28;118(18):1837-47
pubmed: 18852364
Clin Diagn Lab Immunol. 2002 Sep;9(5):972-82
pubmed: 12204946
J Exp Med. 1981 Sep 1;154(3):631-9
pubmed: 7276825
J Biol Chem. 1994 Jan 21;269(3):2241-4
pubmed: 8294481
Infect Immun. 1990 Jul;58(7):2375-82
pubmed: 2114366
Nature. 2002 Jan 24;415(6870):389-95
pubmed: 11807545
Proc Soc Exp Biol Med. 1969 Sep;131(4):1154-8
pubmed: 4897836
J Clin Invest. 1993 Mar;91(3):1028-34
pubmed: 8450032
ACS Chem Biol. 2010 Oct 15;5(10):905-17
pubmed: 20698568
Eur J Biochem. 1993 Dec 1;218(2):555-63
pubmed: 8269946
J Innate Immun. 2012;4(4):327-36
pubmed: 22441679
N Engl J Med. 2000 Aug 3;343(5):338-44
pubmed: 10922424
J Biol Chem. 2004 Jun 18;279(25):26307-13
pubmed: 15096514
N Engl J Med. 1970 Dec 10;283(24):1313-6
pubmed: 5478453